Use of Luofushan Baicao Oil in the preparation of drugs for inhibiting coronavirus oc43 and sars-cov-2 infection in vitro

A sars-cov-2 and coronavirus technology, applied in the field of medicine, can solve problems such as time-consuming and time-consuming research and development cycles, and achieve the effects of non-addiction, convenient use, and broad market prospects

Active Publication Date: 2022-05-10
GUANGDONG LUOFUSHAN SINOPHARM
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the development of new drugs is a time-consuming process, not only the mass production after the R&D cycle is approved, but also a time-consuming project

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of Luofushan Baicao Oil in the preparation of drugs for inhibiting coronavirus oc43 and sars-cov-2 infection in vitro
  • Use of Luofushan Baicao Oil in the preparation of drugs for inhibiting coronavirus oc43 and sars-cov-2 infection in vitro
  • Use of Luofushan Baicao Oil in the preparation of drugs for inhibiting coronavirus oc43 and sars-cov-2 infection in vitro

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] This embodiment provides the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. The medicine is an external preparation, wherein Luofushan Baicao Oil contains the following Components by weight: 25 parts of camphor, 240 parts of methyl salicylate, 90 parts of turpentine oil, 220 parts of peppermint oil, 11 parts of clove basil oil, 120 parts of camphor oil, 14 parts of star anise oil, 15 parts of cinnamon oil, borneol 2 parts, menthol 25 parts, eucalyptus oil 35 parts, tea oil extract 60 parts.

[0047] The tea oil extract is extracted from the tea oil composition. Specifically, the tea oil composition is crushed into a coarse powder, passed through a 30-mesh sieve, mixed evenly, added with 2 times the volume of tea oil, and soaked at 45°C for 25 day, filtered while hot, and the filtrate was cooled to room temperature to obtain camellia oil extra...

Embodiment 2

[0051] This embodiment provides the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. The medicine is an external preparation, wherein Luofushan Baicao Oil contains the following Components in parts by weight: 30 parts of camphor, 280 parts of methyl salicylate, 100 parts of turpentine oil, 300 parts of peppermint oil, 18 parts of clove basil oil, 180 parts of camphor oil, 20 parts of star anise oil, 25 parts of cinnamon oil, borneol 3 parts, menthol 30 parts, eucalyptus oil 45 parts, tea oil extract 100 parts.

[0052] The camellia oil extract is extracted from the camellia oil composition. Specifically, the camellia oil composition is pulverized into a coarse powder, passed through a 30-mesh sieve, mixed and added with 3 times the volume of camellia oil, and soaked at 60°C for 10 day, filtered while hot, and the filtrate was cooled to room temperatur...

Embodiment 3

[0056] This embodiment provides the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory infectious diseases caused by coronavirus infection. The medicine is an external preparation, wherein Luofushan Baicao Oil contains the following Components by weight: 20 parts of camphor, 200 parts of methyl salicylate, 80 parts of turpentine oil, 200 parts of peppermint oil, 10 parts of clove basil oil, 100 parts of camphor oil, 10 parts of star anise oil, 10 parts of cinnamon oil, borneol 2 parts, menthol 20 parts, eucalyptus oil 30 parts, tea oil extract 40 parts.

[0057] The tea oil extract is extracted from the tea oil composition. Specifically, the tea oil composition is crushed into coarse powder, passed through a 30-mesh sieve, mixed evenly, added with 2 times the volume of tea oil, and soaked at 50°C for 15 day, filtered while hot, and the filtrate was cooled to room temperature to obtain camellia oil extract...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses the use of Luofu Mountain Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory system infectious diseases caused by coronavirus infection. The Luofu Mountain Baicao Oil contains the following components in parts by weight: camphor 20 ‑40 parts, methyl salicylate 200‑300 parts, turpentine oil 80‑110 parts, peppermint oil 200‑300 parts, clove basil oil 10‑20 parts, camphor oil 100‑200 parts, star anise oil 10‑30 parts, 10-30 parts of cinnamon oil, 2-4 parts of borneol, 20-35 parts of menthol, 30-50 parts of eucalyptus oil, 40-120 parts of tea oil extract. The various medicinal materials in Luofushan Baicao Oil cooperate with each other and act synergistically to treat both symptoms and root causes, strengthen the body and eliminate pathogenic factors, and have a quick onset and good effect. It has a good clinical effect on respiratory infectious diseases caused by coronavirus infection.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the use of Luofushan Baicao Oil in the preparation of medicines for preventing or treating coronavirus infection or respiratory system infectious diseases caused by coronavirus infection. Background technique [0002] Human coronaviruses were isolated in 1965, but knowledge of them is currently quite limited. In 1967, Mclntosh et al. used human embryo trachea culture to isolate a batch of viruses from cold patients, and its representative strain was OC43 strain. In 1968, Almeida et al. conducted a morphological study on these viruses. Electron microscope observations found that the envelopes of these viruses had corona-like spikes, so they proposed to name these viruses coronaviruses. In 1965, Tyrrell and Bynoe used the ciliated trachea tissue of embryos to cultivate coronavirus for the first time. Under the electron microscope, the virus can be seen as a corona-like peripher...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/61A61K36/896A61K36/9068A61K9/72A61K9/00A61P31/14A61P11/00A61P29/00A61P11/02A61P11/04A61K31/045A61K31/125A61K31/618
CPCA61K31/125A61K31/618A61K36/15A61K36/534A61K36/53A61K36/54A61K36/57A61K31/045A61K36/61A61K36/758A61K36/75A61K36/286A61K36/185A61K36/28A61K36/80A61K36/232A61K36/258A61K36/47A61K36/9064A61K36/237A61K36/9068A61K36/752A61K36/8905A61K36/287A61K36/85A61K36/346A61K36/268A61K36/59A61K36/754A61K36/238A61K36/539A61K36/72A61K36/233A61K36/12A61K36/48A61K36/538A61K36/704A61K36/74A61K36/855A61K36/748A61K36/898A61K36/282A61K36/483A61K36/285A61K36/533A61K36/535A61K36/21A61K36/14A61K36/78A61K36/11A61K36/575A61K36/27A61K36/355A61K36/17A61K36/896A61K36/70A61K36/69A61K9/007A61K9/0014A61P31/14A61P11/00A61P29/00A61P11/02A61P11/04A61K2300/00
Inventor 黄炜忠毛鑫叶耀良陈新泉廖志钟
Owner GUANGDONG LUOFUSHAN SINOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap